Literature DB >> 32461078

Prurigo nodularis: Pathogenesis and management.

Kyle A Williams1, Amy H Huang2, Micah Belzberg1, Shawn G Kwatra3.   

Abstract

Prurigo nodularis is a chronic skin condition characterized by severely pruritic nodules that cause a profound negative impact on quality of life. The second article in this 2-part continuing medical education series focuses on reviewing the pathogenesis of prurigo nodularis and exploring management algorithms for this condition. In addition, we discuss some emerging and novel therapies for treating prurigo nodularis. The first article in this 2-part series describes the broader epidemiology, patient demographics, physical examination findings, and symptoms to aid in the timely recognition and diagnosis of prurigo nodularis.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antipruritic; clinical features; itch; management; pathogenesis; prurigo nodularis; pruritus; therapeutics

Year:  2020        PMID: 32461078     DOI: 10.1016/j.jaad.2020.04.182

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab.

Authors:  Lam C Tsoi; Feriel Hacini-Rachinel; Paul Fogel; Francois Rousseau; Xianying Xing; Matthew T Patrick; Allison C Billi; Celine C Berthier; J Michelle Kahlenberg; Anne Lazzari; Henning Wiegmann; Sonja Ständer; Christophe Piketty; Valerie Julia; Jayendra Kumar Krishnaswamy; Johann E Gudjonsson
Journal:  J Allergy Clin Immunol       Date:  2021-11-29       Impact factor: 14.290

2.  Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans.

Authors:  Nishadh Sutaria; Martin Prince Alphonse; Melika Marani; Varsha Parthasarathy; Junwen Deng; Shannon Wongvibulsin; Kyle Williams; Youkyung Sophie Roh; Justin Choi; Zachary Bordeaux; Thomas Pritchard; Carly Dillen; Yevgeniy R Semenov; Madan M Kwatra; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-10-27       Impact factor: 7.590

3.  Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report.

Authors:  Ilaria Sammarra; Luigi Bennardo; Eugenio Provenzano; Cataldo Patruno; Steven Paul Nisticò
Journal:  Brain Sci       Date:  2022-05-05

4.  Prurigo Nodularis Is Characterized by Systemic and Cutaneous T Helper 22 Immune Polarization.

Authors:  Micah Belzberg; Martin Prince Alphonse; Isabelle Brown; Kyle A Williams; Raveena Khanna; Byron Ho; Shannon Wongvibulsin; Thomas Pritchard; Youkyung Sophie Roh; Nishadh Sutaria; Justin Choi; Jaroslaw Jedrych; Andrew D Johnston; Kakali Sarkar; Chirag Vasavda; Jimmy Meixiong; Carly Dillen; Kent Bondesgaard; John F Paolini; Wei Chen; David Corcoran; Nicolas Devos; Madan M Kwatra; Anna L Chien; Nathan K Archer; Luis A Garza; Xinzhong Dong; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2021-03-23       Impact factor: 7.590

Review 5.  Immunotargets and Therapy for Prurigo Nodularis.

Authors:  Angelina Labib; Teresa Ju; Ashley Vander Does; Gil Yosipovitch
Journal:  Immunotargets Ther       Date:  2022-04-26

6.  Efficacy of a Topical Product Containing Purified Omental Lipids and Three Anti-Itching Compounds in the Treatment of Chronic Pruritus/Prurigo Nodularis in Elderly Subjects: A Prospective, Assessor-Blinded, 4-Week Trial with Transepidermal Water Loss and Optical Coherence Tomography Assessments.

Authors:  Marco Ardigò; Chiara Franceschini; Elena Campione; Terenzio Cosio; Caterina Lanna; Luca Bianchi; Massimo Milani
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-12-30

7.  The increased prevalence of keloids in atopic dermatitis patients with allergic comorbidities: a nationwide retrospective cohort study.

Authors:  Hyo-Eun Kwon; Hye-Jin Ahn; Su Jin Jeong; Min Kyung Shin
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

8.  Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series.

Authors:  Nana Luo; Qiuyue Wang; Min Lei; Tianhao Li; Pingsheng Hao
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-12

9.  Chronic Prurigo: Similar Clinical Profile and Burden Across Clinical Phenotypes.

Authors:  Claudia Zeidler; Manuel Pedro Pereira; Sonja Ständer
Journal:  Front Med (Lausanne)       Date:  2021-06-29

10.  Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities.

Authors:  Giuseppe Lanza; Filomena Irene Ilaria Cosentino; Raffaele Ferri; Bartolo Lanuzza; Maddalena Siragusa; Mariangela Tripodi; Carmelo Schepis
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.